COVID-19优先排序建议对泌尿系统恶性肿瘤病理分期的影响:高容量转诊机构的真实世界分析
该真实世界分析比较了本学术转诊机构疫情期间(2020-2021年)与疫情后(2022-2023年)治疗的泌尿系统恶性肿瘤患者的基线与病理特征。机构遵循国际建议,优先处理被定义为「高风险」的病例。共回顾9196例患者(疫情期间4401例 vs 疫情后4785例);除根治性前列腺切除术(1117 vs 1405;p=0.03)和部分肾切除术(609 vs 759;p=0.02)在疫情期间显著较少外,其他疾病手术总量相当;包括疾病分期、肿瘤分级、坏死、淋巴血管侵犯和组织学变异型在内的病理变量按手术时期均无差异。作者认为,紧急时期正确的肿瘤优先排序政策及将肿瘤病例集中至参考中心可降低医疗资源重组相关癌症病情恶化的可能风险。
要点
- 共回顾9196例泌尿系统恶性肿瘤手术患者,疫情期间(2020-2021年)4401例 vs 疫情后(2022-2023年)4785例。
- 根治性前列腺切除术疫情期间1117例 vs 疫情后1405例(p=0.03),部分肾切除术609例 vs 759例(p=0.02),疫情期间显著较少。
- 除上述两种手术外,其他疾病手术总量在两个时期相当。
- 疾病分期、肿瘤分级、坏死、淋巴血管侵犯和组织学变异型等病理特征按手术时期均无差异。
- 作者认为,紧急时期正确的肿瘤优先排序及将病例集中至参考中心可降低医疗资源重组相关癌症病情恶化的可能风险。
适用人群与场景
- 在本学术转诊机构治疗的泌尿系统恶性肿瘤患者,按手术时期分为疫情期间(2020-2021年)和疫情后(2022-2023年)两组。
- 本机构遵循国际建议,优先处理被定义为「高风险」的病例。
处置流程与药物剂量
- 本机构遵循国际建议,优先处理被定义为「高风险」的病例。
研究设计与关键结果
- 研究类型为真实世界分析,共回顾9196例泌尿系统恶性肿瘤患者,按手术时期分组:疫情期间4401例 vs 疫情后4785例。
- 根治性前列腺切除术数量疫情期间1117例 vs 疫情后1405例(p=0.03),疫情期间显著较低。
- 部分肾切除术数量疫情期间609例 vs 疫情后759例(p=0.02),疫情期间显著较低。
- 除上述两种手术外,其他疾病的手术总量在两个时期相当。
- 疾病分期、肿瘤分级、坏死、淋巴血管侵犯和组织学变异型等病理变量按手术时期均无差异。
证据类型、等级与局限
- 证据类型:真实世界分析(单中心学术转诊机构)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,紧急时期正确的肿瘤优先排序政策及将肿瘤病例集中至参考中心可降低医疗资源重组相关癌症病情恶化的可能风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: In response to the COVID-19 pandemic, the European Association of Urology (EAU) Guidelines defined priority groups to guide the prioritization of surgery for urological malignancies. The objective of this study was to evaluate the impact of the COVID-19 prioritization recommendations on tumor pathological characteristics in a real-world setting at our academic referral institution. Methods: We compared baseline and pathological tumor features of all patients with urological malignancies treated during the pandemic period (2020-2021) versus in the post-pandemic period (2022-2023). Our institution adhered to the international recommendations and prioritized those cases defined as "high-risk". Results: Data from 9196 patients treated for urological malignancies were reviewed and grouped according to period of surgery (4401 in the pandemic period vs. 4785 in the post-pandemic period). The overall number of surgical procedures was comparable for all diseases except for the number of radical prostatectomies (1117 vs. 1405; p = 0.03) and partial nephrectomies (609 vs. 759; p = 0.02), which were significantly lower in the pandemic period. Regarding tumor pathological features, none of the recorded variables were found to differ according to period of surgery, including disease stage, tumor grading, presence of necrosis, lymphovascular invasion, and histological variants. Conclusions: A correct policy of prioritization of oncological pathologies during emergency periods and a centralization of oncological cases in reference centers reduce the possible risk of worsening cancer disease features related to the reorganization of healthcare resources.
参考来源
- Grosso AA, Campi R, Di Maida F, et al. Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution. J Clin Med. 2024. PMID: 39408052. doi:10.3390/jcm13195992
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。